Human tissue factor pathway inhibitory factor mutation gene m2TFPI, recombination carrier and recombination microzyme including the same
A technology of tissue factor and inhibitory factor, which is applied in the field of genetic engineering, can solve the problems of inconvenient medication and cost limitation, and achieve the effects of reducing the number of medications, promoting application, and reducing treatment costs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Example 1 Extraction of mTFPI-pPIC9 plasmid DNA
[0036] 100ul of fresh bacterial solution TB1 (containing mTFPI-pPIC9 plasmid) was inoculated in 10ml of LB medium at 37°C and cultured overnight at 250rpm; take 10 250ml Erlenmeyer flasks, add 100ml of medium to each bottle, and inoculate 1ml of the above bacterial solution at 37°C , culture overnight at 250rpm; centrifuge the pellet, resuspend the pellet with 120ml of GTE buffer, add 240mg of dissolving enzyme, shake vigorously to mix, and bathe in water at 30°C for 30min; add 240ml of lysate (freshly prepared with 0.2N NaOH 1% SDS) and gently invert to mix Evenly, let stand for 5min; add 180ml of 5M potassium acetate solution (pH 5.5; 3M potassium acetate, 2M acetic acid), mix by inverting, ice bath for 10min. Centrifuge at 8000rpm for 15min, filter with two layers of gauze, take the supernatant, add an equal volume of isopropanol, mix well and centrifuge at 8000rpm for 20min, take the precipitate; resuspend the precip...
Embodiment 2
[0037] Example 2 Construction of TFPI-containing mutant gene (m 2 TFPI) carrier
[0038] Using the plasmid DNA mTFPI-pPIC9 (constructed by the Genetic Engineering Laboratory of the Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College) as a template, the mutation primer m 0 (5'AAA GGA GGC CTA ATT GAT GAC GAT GAC (AAA ACC AAA AGA) AAA AGA AAG AAG CAG AGA 3'), 3'Aox(5'GAC TGG TTC CAATTG ACA AGC 3'); the first PCR amplification was carried out for forward and reverse primers. After agarose gel electrophoresis, the PCR product was purified with a DNA gel recovery kit (Beijing Dingguo Biotechnology Development Center). Still using the plasmid DNA mTFPI-pPIC9 as a template, the above PCR product and 5'Aox (5'GCA AAT GGC ATT CTG ACA TCC 3') were used as primers for the second PCR amplification (see Figure 1, m 0 , m 1 , m 2 It is a mutation primer, containing a mutation site. 5'Aox and 3'Aox are general primers for Pichia past...
Embodiment 3
[0039] Example 3 Construction and Identification of Recombinant Yeast GS115
[0040] Get the plasmid DNA (m 2 TFPI-pPIC9) was digested with 50u Sac1 for 1 hour. After the plasmid was precipitated with absolute ethanol, it was dissolved in 20ul sterile water. Yeast competent cells were prepared by PEG1000 method. Add 50ug of DNA directly to the competent cells which are still in the frozen state, and put them in a water bath at 37°C for 5 minutes, then add 1.2ml of PEG solution (40% PEG 1000, 0.2M Bicine, pH 8.35), and put them in a water bath at 30°C for 1h. Centrifuge and resuspend the cells with 1.5ml NaCl solution (0.15M NaCl, 10mM Bicine, pH 8.35). Centrifuge again, resuspend the bacteria with 0.2ml NaCl solution (0.15M NaCl, 10mM Bicine, pH 8.35), spread on the RDB selection plate, and incubate at 30°C for 4-6 days (see Figure 2). Pick the clones from the RDB selection plate and inoculate them in 10ml of YPD medium, and culture them at 30°C and 250rpm for 18-24 hours....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com